Fig. 5. Characteristics of clonazepam treatment outcomes in C. albicans-infected patients showing resistance to antifungal treatment. (A) Clonazepam treatment outcome. (B) Disease durations and NRS scores (degree of chief complaints at first visit) according to clonazepam treatment outcomes. NRS, numerical rating scale; C. albicans, Candida albicans. (a) Disease duration, (b) NRS. *p<0.05, p-values were obtained by Mann-Whitney U test.

J Oral Med Pain 2022;47:126-34 https://doi.org/10.14476/jomp.2022.47.3.126

© 2022 J Oral Med Pain